Bridgewater, NJ, United States of America

Leroy Fong Liu

This inventor holds 29 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Cancer Therapeutics. Top assignees: Rutgers, The State University of New Jersey, University of Medicine and Dentistry of New Jersey. Active years: 1998-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leroy Fong Liu. Retrieved from https://idiyas.com/inventor/leroy-fong-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 3)

% Patents Active = 65.5

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 215(Granted Patents)

Location History:

Bridgewater, NJ (US) (1998 - 2013)
Somerset, NJ (US) (2013 - 2017)
New Brunswick, NJ (US) (2010 - 2019)

Company Filing History:

29 out of 1,498

Rutgers, The State University of New Jersey

patents

1 out of 272

University of Medicine and Dentistry of New Jersey

patents

where one patent can have more than one assignee

Years Active: 1998-2019

Loading Chart...

Areas of Expertise:

Topoisomerase-Targeting Agents

Cytotoxic Agents

Heterocyclic Compounds

Therapeutic Compounds

G-Quadruplex Stabilizers

Methylenedioxybenzo Derivatives

Anti-Tumor Agents

Trisbenzimidazoles

Solubilized Poisons

Nitro Substituted Heterocycles

Amino Substituted Agents

Macrocyclic Compounds

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10179789 - Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer (2019-01-15),

2. 9562051 - Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer (2017-02-07),

3. 8518928 - Therapeutic compounds (2013-08-27),

4. 8389721 - Solubilized topoisomerase poisons (2013-03-05),

5. 8093235 - Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA (2012-01-10),

6. 7858627 - Topoisomerase-targeting agents (2010-12-28),

7. 7781587 - Solubilized topoisomerase poisons (2010-08-24),

8. 7517883 - Solubilized topoisomerase poisons (2009-04-14),

9. 7517867 - Topoisomerase-targeting agents (2009-04-14),

10. 7468366 - Cytotoxic agents (2008-12-23),

11. 7319105 - Cytotoxic agents (2008-01-15),

12. 7208492 - Topoisomerase-targeting agents (2007-04-24),

13. 7049315 - Solubilized topoisomerase poisons (2006-05-23),

14. 6995154 - Heterocyclic topoisomerase poisons (2006-02-07),

15. 6992089 - Nitro and amino substituted topoisomerase agents (2006-01-31),

Title: Leroy Fong Liu: Pioneering Inventor from Bridgewater

Introduction: Leroy Fong Liu is a distinguished inventor hailing from Bridgewater, NJ. His innovative spirit and dedication to technological advancements have made him a prominent figure in the world of patents and inventions.

Latest Patents: Leroy Fong Liu's latest patents focus on cutting-edge technologies in the fields of artificial intelligence, renewable energy, and sustainable materials. His inventions have garnered attention for their potential to revolutionize various industries.

Career Highlights: With a career spanning over two decades, Leroy Fong Liu has established himself as a trailblazer in the innovation landscape. His work has been recognized with numerous awards and accolades, solidifying his reputation as a visionary inventor.

Collaborations: Leroy Fong Liu has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of technological innovation and driving progress in the patent landscape.

Conclusion: Leroy Fong Liu's contributions to the world of inventions and patents are truly remarkable. His relentless pursuit of innovation and commitment to pushing the boundaries of what is possible continue to inspire inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.